Arg753Gln Polymorphisms in the Toll-Like Receptor 2 Gene are Associated with Cytomegalovirus Infection in Egyptian Bone Marrow Recipients

El-Nabi, Sobhy Hassab; Sayed, Samia Youssef; Abdelhafez, Mohamed A.; Elfiky, Mohamed; Moneim, Ahmed E. Abdel; El-Garawani, Islam

doi:10.2174/1871530319666191018124710

Cited by 8 publications

(11 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similarly, El-Nabi et al 31 reported that the Arg753Gln variant in the TLR2 gene was linked to CMV infection in Egyptian bone marrow recipients. They showed that 85% of the patients screened were G/G homozygous, whereas 15% were G/A heterozygous; there were no patients that were homozygous for (A/A).…”

Section: Discussionmentioning

confidence: 92%

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

Alhabibi¹,

Hassan²,

Elbaky³

et al. 2023

JIR

View full text Add to dashboard Cite

Background Toll-like receptors (TLRs) play an important role in activation of innate and adaptive immune responses. Aim We aimed to detect the association between TLR2 rs5743708 G>A and TLR9 rs5743836 C>T variants and COVID-19 disease susceptibility, severity, and thrombosis by using neutrophil extracellular traps (NETs). Subjects and Methods We included 100 adult COVID-19 patients as well as 100 age- and gender-matched normal controls. Participants were genotyped for TLR2 rs5743708 and TLR9 rs5743836. Citrullinated Histone (H3) was detected as an indicator of NETs. Results The mutant (G/A and C/C) genotypes and (A and C) alleles of TLR2 rs5743708 and TLR9 rs5743836, respectively, have been significantly related to a higher risk of COVID-19 infection, representing a significant risk factor for the severity of COVID-19. There was no significant association between the two variants and citrullinated histone (H3). Conclusion TLR2 rs5743708 and TLR9 rs5743836 variants have been significantly related to a higher risk and severity of COVID-19 infection but had no effect on thrombus formation.

show abstract

Section: Discussionmentioning

confidence: 92%

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

Alhabibi¹,

Hassan²,

Elbaky³

et al. 2023

JIR

View full text Add to dashboard Cite

show abstract

“…1 In the last few decades, important measures have been adopted to control and prevent viral infections across the globe. 2,3 These measures include the introduction of a safe and effective vaccine against HBV infection for all newborns and high-risk groups in all WHO member countries, screening of blood and blood derivatives 4 and the implementation of more efficient tests such as nucleic acid testing (NAT). 5 In addition, treatments for chronic HBV infection have been updated and their efficiency improved.…”

Section: Introductionmentioning

confidence: 99%

Anti‐HBcand hepatitis B virusDNAamongHBsAg‐negative blood donors from the main central blood bank units in Eastern Libya

El-Nabi

El-Garawani

Ismail

et al. 2020

Transfusion Medicine

View full text Add to dashboard Cite

Background: Post-transfusion hepatitis B virus (PTHB) infection is still a public health problem in the world. In many developed countries, nucleic acid testing (NAT) for detection of Hepatitis B Virus (HBV)-DNA has been implemented to enhance blood donation safety. In Libya, however, the testing for HBV infection is limited to the detection of HBV surface antigen (HBsAg) only. Objectives: To determine the frequency of anti-Hepatitis B core antibody (HBc) and HBV-DNA in HBsAg-negative, anti-HBc-positive blood donors in the main Central Blood Bank Units (CBBUs) in eastern Libya. Methods: One thousand blood samples were obtained from healthy blood donors at the five main CBBUs in eastern Libya. The samples were screened for HBsAg and anti-HBc. Real-time polymerase chain reaction (PCR) was carried out to detect HBV-DNA in all anti-HBc-positive samples. Results: A total of 94 (9.4%) donors were positive for anti-HBc. Of the 94 anti-HBcpositive samples, 9 samples (9.5%) tested positive for HBV-DNA by real-time PCR. Conclusion: The rate of anti-HBc among blood donors in this study (9.4%) was similar to that reported from other regions in the country. In the absence of advanced tests for the detection of HBV infection in blood donors, such as NAT, anti-HBc should be routinely tested for, at least for first-time donors.

show abstract

“…The valvuloseptal heart defect may occur due to disruptions in the signal transformation of endocardial cushions [12]. TGFBR2 is expressed during heart development in embryonic myocytes, endothelial cells, and endocardial cushion of mice [13].…”

Section: Introductionmentioning

confidence: 99%

Association of TGFBR2 gene polymorphisms (rs6785358 and rs764522) with congenital heart disease susceptibility in Egyptians

Dawood,

Shabana,

El-Midany

et al. 2024

Exploration of Medicine

Self Cite

View full text Add to dashboard Cite

Aim: Transforming growth factor beta (TGF-β) receptor II (TGFBR2) is a basic constituent of TGF-β signalling pathway and is important in heart development. This study investigates the relationship between TGFBR2 gene variance and congenital heart defects (CHD) among Egyptians. Methods: The study involved 75 CHD-affected subjects and 100 healthy controls. Genotyping of two selected tag single nucleotide polymorphisms (tagSNPs, rs6785358, rs764522) within the TGFBR2 gene was conducted using polymerase chain reaction-restriction fragment length polymorphism method (PCR-RFLP) assays. Results: Significant genotype differences were found for rs764522 and rs6785358 (P < 0.05). In the case of rs6785358, the G/G genotype was more prevalent in cases than controls (18.7% vs. 4.0%). This significance was observed in both the codominant model [A/A vs. A/G vs. G/G; odds ratio (OR) = 0.20, 95% confidence interval (CI) = 0.06–0.66, P = 0.0073] and the recessive model (A/A + A/G vs. G/G; OR = 0.19, 95% CI = 0.06–0.60, P = 0.0018). For rs764522, the G/G genotype was more prevalent in cases than controls (21.3% vs. 0.0%). Significant associations were observed in the codominant model (C/C vs. C/G vs. G/G; OR = 0.43, 95% CI = 0.02–0.90, P < 0.0001), as well as in the dominant model (C/C vs. C/G + G/G) and recessive model (C/C + C/G vs. G/G; P < 0.0001). Gender-specific analysis indicated that the C/G genotype was less common in male cases compared to females and controls (OR = 0.24, 95% CI = 0.07–0.84). For rs6785358, the G/G genotype frequency was higher in male cases compared to females and controls (OR = 0.10, 95% CI = 0.01–0.88 and OR = 0.22, 95% CI = 0.05–0.94, respectively). Conclusions: These findings indicate that TGFBR2 gene SNPs (rs6785358 and rs764522) may be risk factors for CHD in Egyptians.

show abstract

Arg753Gln Polymorphisms in the Toll-Like Receptor 2 Gene are Associated with Cytomegalovirus Infection in Egyptian Bone Marrow Recipients

Cited by 8 publications

References 26 publications

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

Anti‐HBcand hepatitis B virusDNAamongHBsAg‐negative blood donors from the main central blood bank units in Eastern Libya

Association of TGFBR2 gene polymorphisms (rs6785358 and rs764522) with congenital heart disease susceptibility in Egyptians

Contact Info

Product

Resources

About